BioCentury
ARTICLE | Finance

IPO Watch

GI company Ventrus prices IPO; but Sweden's Moberg Derma pulls offering

December 20, 2010 8:00 AM UTC

Ventrus Biosciences Inc. (NASDAQ:VTUS) got its IPO done Friday at the bottom of its range, but shares managed to trade up $0.30 to $6.30 on the day.

The specialty GI play sold a bumped up 2.9 million shares at $6, raising $17.4 million and valuing the company at $38.3 million. Ventrus amended its S-1 last month to sell 2.8 million shares at $6-$7...